Cited by 92Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsDiet, Metabolism, and Disease

Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation

Open access
Hoy, Andrew J., Brandon, Amanda E., Turner, Nigel, Watt, Matthew J., Bruce, Clinton R., Cooney, Gregory J., Kraegen, Edward W.·2009·American Journal of Physiology-Endocrinology and Metabolism

Abstract

Type 2 diabetes is characterized by hyperlipidemia, hyperinsulinemia, and insulin resistance. The aim of this study was to investigate whether acute hyperlipidemia-induced insulin resistance in the presence of hyperinsulinemia was due to defective insulin signaling. Hyperinsulinemia (∼300 mU/l) with hyperlipidemia or glycerol (control) was produced in cannulated male Wistar rats for 0.5, 1 h, 3 h, or 5 h. The glucose infusion rate required to maintain euglycemia was significantly reduced by 3 h with lipid infusion and was further reduced after 5 h of infusion, with no difference in plasma insulin levels, indicating development of insulin resistance. Consistent with this finding, in vivo skeletal muscle glucose uptake (31%, P < 0.05) and glycogen synthesis rate (38%, P < 0.02) were significantly reduced after 5 h compared with 3 h of lipid infusion. Despite the development of insulin resistance, there was no difference in the phosphorylation state of multiple insulin-signaling intermediates or muscle diacylglyceride and ceramide content over the same time course. However, there was an increase in cumulative exposure to long-chain acyl-CoA (70%) with lipid infusion. Interestingly, although muscle pyruvate dehydrogenase kinase 4 protein content was decreased in hyperinsulinemic glycerol-infused rats, this decrease was blunted in muscle from hyperinsulinemic lipid-infused rats. Decreased pyruvate dehydrogenase complex activity was also observed in lipid- and insulin-infused animals (43%). Overall, these results suggest that acute reductions in muscle glucose metabolism in rats with hyperlipidemia and hyperinsulinemia are more likely a result of substrate competition than a significant early defect in insulin action or signaling.

Integrity signals

Registry

Crossref · 10.1152/ajpendo.90945.2008

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Even following a short period of overfeeding, cardiac and skeletal muscle develop insulin resistance in order to divert the excess energy into adipose tissue.

    “Even following a short period of overfeeding, cardiac and skeletal muscle develop insulin resistance in order to divert the excess energy into adipose tissue [125].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [125]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoy, A. J., Brandon, A. E., Turner, N., Watt, M. J., Bruce, C. R., Cooney, G. J., & Kraegen, E. W.
Affiliations
Garvan Institute of Medical Research (AU)
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2009-07
Volume
297
Issue
1
Pages
E67-E75
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2160416826
Cited by
92
References
9
Citations by year
2026: 5 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 7
FWCI
3.49
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK067509, DK-067509)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
skeletal muscle insulin resistance, hyperlipidemia, hyperinsulinemia, lipid infusion, insulin signaling, IRS-1 phosphorylation, Akt phosphorylation, AS160 phosphorylation, substrate competition, PDK4, pyruvate dehydrogenase complex, muscle glucose uptake, glycogen synthesis, long-chain acyl-CoA, diacylglycerol, ceramide, type 2 diabetes
MeSH terms
Animals, Blood Glucose, Glycogen, Infusions, Intravenous, Insulin, Insulin Resistance, Lipids, Male, Phosphorylation, Rats, Wistar, Muscle, Skeletal, GTPase-Activating Proteins, Feedback, Physiological, Oncogene Protein v-akt, Rats, Metabolic Networks and Pathways, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review